Roivant Sciences (ROIV) Gains (Losses) on Sale of Assets & Investments (2020 - 2026)
Roivant Sciences (ROIV) recorded Non Operating Investment Income of $36.64 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$19.13 million a year earlier.
Powered by 
Analysis
Roivant Sciences (ROIV) Gains (Losses) on Sale of Assets & Investments (2020 - 2026) Analysis & Trends
On a TTM basis, Roivant Sciences' Non Operating Investment Income came in at $160.81 million as of Jun 30, 2026, up 671.8% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $105.05 million, up 90.3% from FY2025.
- Annual Non Operating Investment Income has a five-year compound annual growth rate of 1.9% (FY2021 to FY2026).
- Across earlier fiscal years, Non Operating Investment Income came in at $55.19 million in FY2025, -$47.97 million in FY2024, $29.28 million in FY2023 (-93.4%) and $443.75 million in FY2022 (+364.5%).
- Quarterly Non Operating Investment Income has ranged from -$54.68 million in fiscal Q2 2023 to $443.75 million in fiscal Q2 2022 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at -$25.92 million (Q4 2026), $21.59 million (Q3 2026) and $128.5 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Roivant Sciences | 29.81 Bn | 13.51 Bn | 31.77 Mn | 60.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 60.29 Mn |
| Jun 30, 2026 | 36.64 Mn |
| Mar 31, 2026 | -25.92 Mn |
| Dec 31, 2025 | 21.59 Mn |
| Sep 30, 2025 | 128.50 Mn |
| Jun 30, 2025 | -19.13 Mn |
| Mar 31, 2025 | 12.90 Mn |
| Dec 31, 2024 | -21.31 Mn |
| Sep 30, 2024 | 48.38 Mn |
| Jun 30, 2024 | 15.23 Mn |
| Mar 31, 2024 | 15.91 Mn |
| Dec 31, 2023 | -10.47 Mn |
| Sep 30, 2023 | -45.85 Mn |
| Jun 30, 2023 | -7.56 Mn |
| Mar 31, 2023 | 82.55 Mn |
| Dec 31, 2022 | 25.95 Mn |
| Sep 30, 2022 | -54.68 Mn |
| Jun 30, 2022 | -24.55 Mn |
| Dec 31, 2021 | -38.04 Mn |
| Sep 30, 2021 | 443.75 Mn |
API Access
Roivant Sciences Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();